Diagnosis of acromegaly in a patient with type 1 diabetes mellitus

Endocrine Practice

Volumn 8, Issue 2, 2002, Pages 113-118

  Hofmann, Elisa A ^a   Polonsky, Kenneth S ^a   Weiss, Roy E ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; BINDING PROTEIN; BROMOCRIPTINE; CALCIUM; CREATININE; ENALAPRIL; ESTRADIOL; FOLLITROPIN; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; INSULIN; ISOPHANE INSULIN; OCTREOTIDE; PARATHYROID HORMONE; PHOSPHORUS; PIRENZEPINE; PROLACTIN; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ACROMEGALY; ADULT; AMENORRHEA; ARTICLE; BLOOD GLUCOSE MONITORING; CASE REPORT; DIFFERENTIAL DIAGNOSIS; ESTRADIOL BLOOD LEVEL; FEMALE; FOLLITROPIN BLOOD LEVEL; GROWTH HORMONE RELEASE; HUMAN; HYPERTENSION; HYPOPHYSIS ADENOMA; IMMUNOHISTOCHEMISTRY; INSULIN DEPENDENT DIABETES MELLITUS; NEUROPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; ORAL GLUCOSE TOLERANCE TEST; POSTOPERATIVE PERIOD; PROVOCATION TEST; TRANSSPHENOIDAL SURGERY;

EID: 0036127605     PISSN: 1530891X     EISSN: None     Source Type: Journal    
DOI: 10.4158/ep.8.2.113     Document Type: Article

References (31)

1. Loss of the normal relationships between growth hormone, growth hormone-binding protein and insulin-like growth factor-1 in adolescents with insulin-dependent diabetes mellitus
2. Serum insulin-like growth factor I levels in adult diabetic patients: The effect of age
3. Somatomedin-C and diabetic retinopathy
4. Evidence that upregulation of serum IGF-1 concentration can trigger acceleration of diabetic retinopathy
5. Insulin-like growth factors in vitreous: Studies in control and diabetic subjects with neovascularization
6. Progression of diabetic retinopathy and changes in serum insulin-like growth factor I (IGF I) during continuous subcutaneous insulin infusion (CSII)
7. Relationship between prorenin, IGF-I, IGF-binding proteins and retinopathy in diabetic patients
8. Association of elevated IGF-I levels with increased retinopathy in late-onset diabetes
9. Is insulinlike growth factor I associated with diabetic retinopathy?
10. Growth hormone in type I diabetic and healthy man
11. Circulating insulin-like growth factor I in type 1 (insulin-dependent) diabetic patients with retinopathy
12. Somatomedin-C (SM-C): Study in diabetic patients with and without retinopathy
13. A two-year follow-up study of serum insulinlike growth factor-I in diabetics with retinopathy
14. Serum insulin-like growth factor-binding protein-3 levels in the diagnosis of acromegaly
15. Benign and malignant tumors in patients with acromegaly
16. Mortality and cancer incidence in acromegaly: A retrospective cohort study
17. Mortality in acromegaly
18. Criteria for cure of acromegaly: A consensus statement
19. Enhanced sensitivity growth hormone (GH) chemiluminescence assay reveals lower postglucose nadir GH concentrations in men than women
20. Characterization of 24-hour growth hormone secretion in acromegaly: Implications for diagnosis and therapy
21. Clinical review 75: Recent advances in pathogenesis, diagnosis, and management of acromegaly
22. Usefulness of different biochemical markers of the insulin-like growth factor (IGF) family in diagnosing growth hormone excess and deficiency in adults
23. The pituitary "incidentaloma"
24. Characteristics of the somatotropic axis in insulin dependent diabetes mellitus
25. Natural course of growth hormone hypersecretion in insulin-dependent diabetes mellitus
26. Insulin-like growth factors: Studies in diabetics with and without retinopathy
27. Plasma somatomedin activity and diabetic retinopathy
28. Abnormal growth hormone response to ingestion of glucose in juvenile diabetics
29. Diagnosis and endocrine testing in acromegaly
30. Elevated serum growth hormone in a patient with type 1 diabetes: A diagnostic dilemma
31. IGFBP-3 is a poor parameter for assessment of clinical activity in acromegaly